Sales 2024 * 1,784B 1.32B Sales 2025 * 1,870B 1.39B Capitalization 4,107B 3.05B
Net income 2024 * 586B 435M Net income 2025 * 640B 475M EV / Sales 2024 * 2.3 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 2.2 x
P/E ratio 2024 *
6.75 x
P/E ratio 2025 *
6.26 x
Employees 2,170
Yield 2024 *
6.31%
Yield 2025 *
6.71%
Free-Float 37.91%
More Fundamentals * Assessed data
Dynamic Chart
Ray Co., Ltd. announced that it has received KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd. CI
Jin Young Co.,Ltd. announced that it has received KRW 10 billion in funding from KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Kiwoom Securities Co., Ltd., JB Woori Capital Co., Ltd, HisStory Investment Management, Shinhan Investment & Securities Co., Ltd. CI
Ray Co., Ltd. announced that it expects to receive KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd. CI
Jin Young Co.,Ltd. announced that it expects to receive KRW 10 billion in funding from KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Kiwoom Securities Co., Ltd., JB Woori Capital Co., Ltd, HisStory Investment Management, Shinhan Investment & Securities Co., Ltd. CI
CORESTEMCHEMON Inc. announced that it expects to receive KRW 21 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and another investor CI
OliX Pharmaceuticals, Inc announced that it has received KRW 14.7 billion in funding from a group of investors CI
OliX Pharmaceuticals, Inc announced that it expects to receive KRW 14.7 billion in funding from a group of investors CI
Cytogen, Inc. announced that it has received KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors CI
Micro Digital Co., Ltd. announced that it has received KRW 9 billion in funding from Mirae Asset Securities Co., Ltd., Samsung Securities Co., Ltd., Korea Investment & Securities Co., Ltd., Shinhan Bank Co., Ltd., NH Investment & Securities Co., Ltd., Winvest Venture Partners Inc. CI
Cytogen, Inc. announced that it expects to receive KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors CI
Micro Digital Co., Ltd. announced that it expects to receive KRW 9 billion in funding from Mirae Asset Securities Co., Ltd., Samsung Securities Co., Ltd., Korea Investment & Securities Co., Ltd., Shinhan Bank Co., Ltd., NH Investment & Securities Co., Ltd., Winvest Venture Partners Inc. and another investor CI
SIMMTECH Co., Ltd. announced that it has received KRW 100 billion in funding from a group of investors CI
NH Investment & Securities Co., Ltd. announces an Equity Buyback for 4,173,622 shares. CI
Meta Biomed Co., Ltd. announced that it has received KRW 24 billion in funding from Mirae Asset Securities Co., Ltd., Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., KB-Suseong No. 1 New Technology Business Investment Association CI
NH Investment & Securities Co., Ltd. authorizes a Buyback Plan. CI
More news
1 day-4.53%
1 week-8.39%
Current month+0.43%
1 month+2.08%
3 months+14.13%
6 months+15.36%
Current year+14.13%
More quotes
1 week
11 560.00
Extreme 11560
12 940.00
1 month
11 560.00
Extreme 11560
13 100.00
Current year
9 730.00
Extreme 9730
13 100.00
1 year
8 650.00
Extreme 8650
13 100.00
3 years
8 250.00
Extreme 8250
13 700.00
5 years
6 300.00
Extreme 6300
15 000.00
10 years
6 300.00
Extreme 6300
17 650.00
More quotes
Managers TitleAgeSince
Chief Operating Officer 57 -
Compliance Officer - 19-12-25
Chief Tech/Sci/R&D Officer 56 19-01-06
Members of the board TitleAgeSince
Director/Board Member 69 20-03-24
Director/Board Member 65 -
Director/Board Member 71 18-03-21
More insiders
Date Price Change Volume
24-03-28 11,790 -4.53% 1,815,960
24-03-27 12,350 -3.14% 1,379,841
24-03-26 12,750 -0.31% 911,700
24-03-25 12,790 -1.08% 924,450
24-03-22 12,930 +0.47% 1,240,609

End-of-day quote Korea S.E., March 27, 2024

More quotes
NH Investment & Securities Co Ltd, formerly Woori Investment & Securities Co Ltd, is a Korea-based company principally engaged in the financial investment business. The Company operates its business through four segments. The Trading segment is engaged in the commodity management including stocks and bonds, derivatives supply, as well as equity capital investment. The Sales segment provides asset management services such as stocks brokerage and financial product sales to individuals and institutional investors. The Investment Bank (IB) segment offers services related to corporate finance, including corporate funding, merger and acquisition (M&A), and private equity fund (PEF) operations. The Headquarter and Other segment is involved in the headquarter management, among others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
11,790 KRW
Average target price
13,273 KRW
Spread / Average Target
+12.58%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock NH Investment & Securities Co., Ltd. - Korea S.E.